Table 2 Characteristics of included studies on the survival outcomes of endometrial cancer
Author (year) | Region | Design | Percentage of stages I–II, % | No. of patients | Age (year) | Diabetic patients, % | Adjusted variables | Outcomes | Subgroups | Follow-up duration |
|---|---|---|---|---|---|---|---|---|---|---|
Ko et al. (2014) [41] | USA | Retrospective | 82 | 363 | 63 | 100 | Age, stage, grade, histology, adjuvant treatment | TTR, RFS, OS | None | 2005–2010 |
Nevadunsky et al. (2014) [9] | USA | Retrospective | 75 | 985 | 64 | 75 | Age, clinical stage, grade, chemotherapy, radiation, hyperlipidemia | OS | Diabetes | 1999–2009 |
Lemanska et al. (2015) [42] | Poland | Retrospective | 75 | 107 | 64 | 64 | Age, diabetes, hypertension, BMI, glucose level, grade, stage, hysterectomy, radiation, endometrial cancer type | OS | Histological type | 2002–2010 |
Ezewuiro et al. (2016) [44] | USA | Retrospective | 0 | 349 | 63 | 17 | study site, BMI, race, age, stage | OS, recurrence | Diabetes | 1992–2011 |
Hall et al. (2016) [10] | USA | Retrospective | 79 | 351 | 58 | 18 | None | Recurrence | None | 2005–2011 |
Al Hilli et al. (2016) [43] | USA | Retrospective | 81 | 1303 | 65 | 21 | Age, BMI, smoking, ASA score, cardiopulmonary state, various tumor features, surgery, adjuvant therapy | OS, PFS | Histological type, diabetes | 1999–2008 |
Seebacher et al. (2016) [45] | Austria | Retrospective | 70 | 465 | 65 | 19 | Age, tumor stage, grade, histological subtype | CSS, OS, RFS, recurrence | None | 1995–2011 |